[Congressional Record Volume 159, Number 82 (Tuesday, June 11, 2013)]
[Extensions of Remarks]
[Pages E843-E844]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]




                      CONGRATULATING MICHAEL ROSEN

                                 ______
                                 

                       HON. JANICE D. SCHAKOWSKY

                              of illinois

                    in the house of representatives

                         Tuesday, June 11, 2013

  Ms. SCHAKOWSKY. Mr. Speaker, I rise to congratulate Michael Rosen as 
he receives the inaugural Patient Impact Legacy Award from the Cures 
Within Reach Foundation for his work in the BioSciences over the last 
30 years.
  Michael Rosen has been chosen to receive this inaugural Legacy Award 
based on his leadership and involvement in the BioScience industry and 
his interest in the betterment of the regional community. Currently the 
Senior Vice President of the Forest City Science + Technology Group, 
Rosen is responsible for developing marketing strategies for Forest 
City's biotech projects across the United States and serves as their 
liaison to the life science industry developing relationships with 
clients and major research universities. Forest City Science + 
Technology Group is one of the country's leading developers & owners of 
science parks associated with leading research-based universities. He 
is also a founding member, current board member and former vice-
chairman of IBIO, the Illinois Biotechnology Industry Organization, and 
chairman of its predecessor organization. Prior to Forest City, Mr. 
Rosen spent 32 years as an executive in the pharmaceutical, biotech and 
medical device industries in the U.S. and abroad working in Europe, 
Asia and Latin America.
  The Cures Within Reach Midwest BioScience Industry Campaign event 
will occur annually to celebrate both the industry in our region, and 
its commitment to life-changing solutions for patients. Cures Within 
Reach was founded in 2005 as a Chicago-based not-for-profit 
organization helping patients by repurposing FDA-approved drugs and 
devices to deliver fast, safe and affordable treatments for diseases 
and rare disorders that have insufficient or nonexistent therapies. 
Cures Within Reach has emerged as a leader in the repurposing 
revolution, working to transform patient lives through research that 
looks backward to move forward.
  Past research has delivered seven treatments in use today in major 
disease areas and rare disorders including Multiple Sclerosis, 
Autoimmune Lymphoproliferative Syndrome, Lung Cancer, Prostate Cancer, 
and Familial Dysautonomia. Current research projects are in process at 
many select institutional partners, including The Mayo Clinic, the 
Seattle Children's Hospital, Rush University, The University of 
Chicago, Weill Cornell, and the Children's Hospital of Philadelphia.
  I join others in the Chicago area in offering my deep gratitude for 
Michael's decades of work and lifelong commitment to patients and the 
bioscience that heals them, and to Cures Within Reach. I wish them well 
and ask this body to do the same on this momentous occasion.

[[Page E844]]



                          ____________________